This study provides proof-of-principle data for the use of trained immunity to modulate macrophage interactions with tumours. The study makes a valuable contribution to the field of trained immunity.

On March 17, 2025, Monogram (NASDAQ:MGRM) announced that the FDA has granted 510(k) clearance for its Monogram mBôs TKA System. This determination means that the company can move forward with ...

Dezeen Showroom: trapezoidal hand-blown glass elements come together in a ring to form the Polaris chandelier by Los Angeles-based design studio Bianco Light + Space. Forming part of the studio's ...

Getty (2) Kate Middleton has reset her royal role upon her return to public duties one year after revealing her cancer diagnosis. On Jan. 14, the Princess of Wales announced that her cancer is in ...

seamlessly blending artful imperfection with enduring performance to create environments that are elevated and inviting," said Designtex executive design director Sara Balderi. Fresco is low-VOC ...

Monogram Technologies received Food and Drug Administration 510(k) clearance for its mBôS TKA System for total knee replacements and will now work toward commercializing the system, the Austin, ...

Ben Sexson, Monogram Chief Executive Officer, commented, "This FDA 510(k) clearance is a defining moment for Monogram. It marks the culmination of years of relentless effort, innovation ...